Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 36.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of HUTCHMED (China) was 64.80% per year. The lowest was -75.70% per year. And the median was -32.60% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
HUTCHMED (China) 3-Year FCF Growth Rate Related Terms
HMDCF vs ZTS, UTHR, VTRS: 3-Year FCF Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HUTCHMED (China) 3-Year FCF Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where HUTCHMED (China)'s 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 36.40% mean?
HUTCHMED (China) (HMDCF) has a 3-Year FCF Growth Rate of 36.40% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for HUTCHMED (China) and its competitors. According to the industry distribution chart, HUTCHMED (China) ranks #148 out of 658 companies in the Drug Manufacturers industry, placing it in the top 22.5%.
Is HUTCHMED (China)'s 3-Year FCF Growth Rate too high?
HUTCHMED (China)'s current 3-Year FCF Growth Rate is 36.40%. The Drug Manufacturers industry median 3-Year FCF Growth Rate is 8.95. HUTCHMED (China)'s value of 36.40% is 306.7% above this industry median. Based on the distribution chart, HUTCHMED (China) ranks #148 out of 658 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, HUTCHMED (China) has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does HUTCHMED (China)'s 3-Year FCF Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, HUTCHMED (China) ranks #148 out of 658 companies for 3-Year FCF Growth Rate. This places HUTCHMED (China) in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 8.95. HUTCHMED (China)'s value of 36.40% is 306.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Drug Manufacturers company?
The median 3-Year FCF Growth Rate among Drug Manufacturers companies is 8.95, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HUTCHMED (China)'s current 3-Year FCF Growth Rate of 36.40% is 306.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for HUTCHMED (China) and its competitors. For the Drug Manufacturers industry, the median 3-Year FCF Growth Rate is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HUTCHMED (China)'s current 3-Year FCF Growth Rate is 36.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HUTCHMED (China) stock overvalued right now?
HUTCHMED (China) (HMDCF) has a current 3-Year FCF Growth Rate of 36.40%. The stock's GF Value™ is $2.35, compared to a current price of $2.16 — trading 8.1% below its estimated fair value. The current 3-Year FCF Growth Rate is 36.40% and 306.7% above the Drug Manufacturers industry median of 8.95. HUTCHMED (China)'s overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For HUTCHMED (China) (HMDCF), the current 3-Year FCF Growth Rate is 36.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HUTCHMED (China) (HMDCF) Overvalued in 2026?
Based on GuruFocus' analysis, HUTCHMED (China) stock appears to be undervalued.
The current stock price of $2.16 is trading 8.1% below its estimated GF Value™ of $2.35.
Key valuation signals for HMDCF:
3-Year FCF Growth Rate: 36.40%
GF Value™: $2.35 vs. price of $2.16 (8.1% below fair value)
Industry Position: 306.7% above the Drug Manufacturers median (#148 of 658)
No single metric tells the full story. See the HMDCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
66GF Score
Get the complete analysis for HMDCF
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HMDCF has been successfully added to your 
